Institutional investors purchased a net $2.9 million shares of NVO during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 9.16% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OXFORD ASSET MANAGEMENT LLP Bought 170.7 Thousand shares of Novo Nordisk
CHAUTAUQUA CAPITAL MANAGEMENT LL... Bought 144.7 Thousand shares of Novo Nordisk
ICON ADVISERS, INC. Bought 121.5 Thousand shares of Novo Nordisk